Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?

References

• Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol. 2020. doi:10.1016/j.jacc.2020.03.031
   Web of Science ®Google Scholar
• Zhang T, Sun LX, Feng RE. Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019. Zhonghua Jie He Hu Xi Za Zhi. 2020;43:E040.
   Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 May;395(10234):1417–1418. doi: 10.1016/S0140-6736(20)30937-5
   PubMed Web of Science ®Google Scholar
• Nelemans T, Kikkert M. Viral innate immune Evasion and the pathogenesis of emerging RNA virus infections. Viruses. 2019 Oct;11(10). pii: E961. doi: 10.3390/v11100961
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 Mar. doi:10.1016/S1473-3099(20)30232-2
   Web of Science ®Google Scholar
• Kikkert M. Innate immune evasion by human respiratory RNA viruses. J Innate Immun. 2020 Jan;12(1):4–20. doi: 10.1159/000503030
   PubMed Web of Science ®Google Scholar
• Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020 May;6:31. doi: 10.1038/s41421-020-0168-9
   PubMed Web of Science ®Google Scholar
• Lim HK, Huang SXL, Chen J, et al. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 2019 Sept. 2;216(9):2038–2056. doi: 10.1084/jem.20181621
   PubMed Web of Science ®Google Scholar
• Berthelot JM, Lioté F. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta. EBioMedicine. Version 2. 2020 Jun;56:102801. doi:10.1016/j.ebiom.2020.102801.
   PubMed Web of Science ®Google Scholar
• Xie J, Li Y, Shen X, et al. Dampened STING-dependent interferon activation in bats. Cell Host Microbe. 2018 Mar;23(3):297–301.e4. doi: 10.1016/j.chom.2018.01.006
   PubMed Web of Science ®Google Scholar
• Zhou R, Xie X, Li X, et al. The triggers of the cGAS-STING pathway and the connection with inflammatory and autoimmune diseases. Infect Genet Evol. 2020 Jan;77:104094. doi: 10.1016/j.meegid.2019.104094
   PubMed Web of Science ®Google Scholar
• Holm CK, Jensen SB, Jakobsen MR, et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol. 2012 Jun;13(8):737–743. doi: 10.1038/ni.2350
   PubMed Web of Science ®Google Scholar
• Maringer K, Fernandez-Sesma A. Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection. Cytokine Growth Factor Rev. 2014 Dec;25(6):669–679. doi: 10.1016/j.cytogfr.2014.08.004
   PubMed Web of Science ®Google Scholar
• Ryan EL, Hollingworth R, Grand RJ. Activation of the DNA damage response by RNA viruses. Biomolecules. 2016 Jan;6(1):2. doi: 10.3390/biom6010002
   PubMed Web of Science ®Google Scholar
• Hamann L, Ruiz-Moreno JS, Szwed M, et al. STING SNP R293Q is associated with a decreased risk of aging-related diseases. Gerontology. 2019 Mar;65(2):145–154. doi: 10.1159/000492972
   PubMed Web of Science ®Google Scholar
• Xu X, Han M, Li T, et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci USA. 2020 Apr. pii: 202005615. doi: 10.1073/pnas.2005615117
   Web of Science ®Google Scholar
• Cantini F, Niccoli L, Matarrese D, et al. Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact. J Infect. 2020 Apr . pii: S0163-4453(20)30228-0. doi: 10.1016/j.jinf.2020.04.017
   Web of Science ®Google Scholar
• Ziegler CGK, Allon SJ, Nyquist SK, et al. SARS-CoV-2 receptor ACE2 Is an interferon-Stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. 2020 May;181:1016–35.e19. doi: 10.1016/j.cell.2020.04.035
   PubMed Web of Science ®Google Scholar
• Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017 Jul;39:529–539. doi: 10.1007/s00281-017-0629-x
   PubMed Web of Science ®Google Scholar
• Jones VG, Mills M, Suarez D, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020 Apr. pii:hpeds.2020-0123. doi: 10.1542/hpeds.2020-0123
   Google Scholar
• Williams M, Nagaraju L, Gorelik M. Complete regression of giant aneurysms in an infant with delayed diagnosis and refractory Kawasaki disease via combination Anticytokine therapy: case report and review of similar cases. Case Rep Rheumatol. 2020 Mar;2020:6249013. doi: 10.1155/2020/6249013
   PubMedGoogle Scholar
• Colonna C, Monzani NA, Rocchi A, et al. Chilblains-like lesions in children following suspected COVID-19 infection. Pediatr Dermatol. 2020 May. doi: 10.1111/pde.14210
   Web of Science ®Google Scholar
• König N, Fiehn C, Wolf C, et al. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis. 2017 Feb;76(2):468-472. Epub 2016 Aug 26. doi: 10.1136/annrheumdis-2016-209841
   PubMed Web of Science ®Google Scholar
• Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014 Aug;371(6):507–518. doi: 10.1056/NEJMoa1312625
   PubMed Web of Science ®Google Scholar
• Hess DC, Eldahsahn W, Rutkwoski E. COVID-19-related stroke. Transl Stroke Res. 2020 May. doi: 10.1007/s12975-020-00818-9
   Web of Science ®Google Scholar
• Rowley AH, Wylie KM, Kim KY, et al. The transcriptional profile of coronary arteritis in Kawasaki disease. BMC Genomics. 2015 Dec;16:1076. doi: 10.1186/s12864-015-2323-5
   PubMed Web of Science ®Google Scholar
• Ko TM, Kuo HC, Chang JS, et al. CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. Circ Res. 2015 Feb;116(5):876–883. doi: 10.1161/CIRCRESAHA.116.305834
   PubMed Web of Science ®Google Scholar
• Kawano Y, Kawada JI, Nagai N, et al. Reactivation of human herpesviruses 6 and 7 in Kawasaki disease. Mod Rheumatol. 2019 Jul;29(4):651–655. doi: 10.1080/14397595.2018.1510758
   PubMed Web of Science ®Google Scholar
• Wang W, Hu D, Wu C, et al. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection. PLoS Pathog. 2020 Mar;16(3):e1008335. doi: 10.1371/journal.ppat.1008335
   PubMed Web of Science ®Google Scholar
• Kakisaka Y, Ohara T, Katayama S, et al. Human herpes virus type 6 can cause skin lesions at the BCG inoculation site similar to Kawasaki disease. Tohoku J Exp Med. 2012 Dec;228(4):351–353. doi: 10.1620/tjem.228.351
   PubMed Web of Science ®Google Scholar
• Dey RJ, Dey B, Singh AK, et al. Bacillus Calmette-Guérin overexpressing an endogenous stimulator of interferon genes agonist provides enhanced protection against pulmonary tuberculosis. J Infect Dis. 2020 Mar;221(7):1048–1056. doi: 10.1093/infdis/jiz116
   PubMed Web of Science ®Google Scholar
• Okada S, Hashimoto S, Miyake A, et al. Kawasaki disease following severe sunburn Injury. Front Pediatr.2020 Jan;8:6. eCollection 2020. doi: 10.3389/fped.2020.00006
   PubMed Web of Science ®Google Scholar
• Luo W, Wang Y, Zhang L, et al. Critical role of cytosolic DNA and its sensing adaptor STING in aortic degeneration, dissection, and rupture. Circulation. 2020 Jan;141(1):42–66. doi: 10.1161/CIRCULATIONAHA.119.041460
   PubMed Web of Science ®Google Scholar
• Stagi S, Rigante D, Lepri G, et al. Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? Clin Rheumatol. 2016 Jul;35(7):1865–1872. doi: 10.1007/s10067-015-2970-6
   PubMed Web of Science ®Google Scholar
• Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020 May. doi: 10.1007/s40520-020-01570-8
   PubMed Web of Science ®Google Scholar
• Rhodes JM, Subramanian S, Laird E, et al. Letter: low population mortality from COVID-19 in countries south of latitude 35 degrees north supports vitamin D as a factor determining severity. Authors’ reply. Aliment Pharmacol Ther. 2020 May. doi: 10.1111/apt.15823
   Web of Science ®Google Scholar
• Coll-Bonfill N, Cancado de Faria R, Bhoopatiraju S, et al. Calcitriol prevents RAD51 loss and cGAS-STING-IFN response triggered by progerin. Proteomics. 2020 Mar;20(5-6):e1800406. doi: 10.1002/pmic.201800406
   PubMed Web of Science ®Google Scholar
• Newling M, Hoepel W, Vogelpoel LTC, et al. Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells. Eur J Immunol. 2018 Nov;48(11):1796–1809. doi: 10.1002/eji.201847615
   PubMed Web of Science ®Google Scholar
• Dai J, Huang YJ, He X, et al. Acetylation blocks cGAS activity and inhibits self-DNA-induced autoimmunity. Cell. 2019 Mar;176(6):1447–1460.e14. doi: 10.1016/j.cell.2019.01.016
   PubMed Web of Science ®Google Scholar
• Yoshizawa H, Nogami K, Matsumoto T, et al. Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays. Thromb Res. 2019 Feb;174:76–83. doi: 10.1016/j.thromres.2018.12.016
   PubMed Web of Science ®Google Scholar
• Gordon JB, Burns JC. Management of sequelae of Kawasaki disease in adults. Glob Cardiol Sci Pract. 2017 Oct;2017(3):e201731. doi: 10.21542/gcsp.2017.31
   PubMedGoogle Scholar
• Sriram K, Insel PA. A hypothesis for pathobiology and treatment of COVID-19: the centrality of ACE1/ACE2 imbalance. Br J Pharmacol. 2020 Apr. doi: 10.1111/bph.15082
   Web of Science ®Google Scholar
• Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors. Eur Heart J. 2020 May. pii:ehaa373. doi: 10.1093/eurheartj/ehaa373
   Web of Science ®Google Scholar
• Verdecchia P, Cavallini C, Spanevello A, et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med. 2020 Apr. pii:S0953-6205(20)30151-5. doi: 10.1016/j.ejim.2020.04.037
   Web of Science ®Google Scholar
• Zhang Y, Chen W, Wang Y. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER). Biomed Pharmacother. 2020 May;125:110022. doi: 10.1016/j.biopha.2020.110022
   PubMed Web of Science ®Google Scholar
• Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016 Feb;22(2):146–153. doi: 10.1038/nm.4027
   PubMed Web of Science ®Google Scholar
• Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 Apr. pii: S0049-3848(20)30120-1. doi: 10.1016/j.thromres.2020.04.013
   Web of Science ®Google Scholar
• Zhai Z, Li C, Chen Y, et al. Prevention and treatment of venous Thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines. Thromb Haemost. 2020 Apr. doi: 10.1055/s-0040-1710019
   Web of Science ®Google Scholar
• Whyte CS, Morrow GB, Mitchell JL, et al. Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J Thromb Haemost. 2020 Apr. doi: 10.1111/jth.14872
   Web of Science ®Google Scholar
• Chia J, Eroglu FK, Özen S, et al. Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy. J Am Acad Dermatol. 2016 Jan;74(1):186–189. doi: 10.1016/j.jaad.2015.10.007
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cao W, Xiao M, et al. Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonhgua Xue Ye Xue Za Zhi. 2020 Mar;41( 0):E006. doi: 10.3760/cma.j.issn.0253-2727.2020.0006
   PubMedGoogle Scholar
• Bowles L, Platton S, Yartey N, et al. Lupus anticoagulant and Abnormal coagulation Tests in patients with COVID-19. N Engl J Med. 2020 May. doi: 10.1056/NEJMc2013656
   Web of Science ®Google Scholar
• Mao Y, Luo W, Zhang L, et al. STING-IRF3 Triggers endothelial inflammation in response to Free Fatty Acid-induced mitochondrial damage in Diet-induced obesity. Arterioscler Thromb Vasc Biol. 2017 May;37(5):920–929. doi: 10.1161/ATVBAHA.117.309017
   PubMed Web of Science ®Google Scholar
• Yang X, Cheng X, Tang Y, et al. The role of type 1 interferons in coagulation induced by gram-negative bacteria. Blood. 2020 Apr;135(14):1087–1100. doi: 10.1182/blood.2019002282
   PubMed Web of Science ®Google Scholar
• Zhang H, Zeng L, Xie M, et al. TMEM173 Drives lethal coagulation in sepsis. Cell Host Microbe. 2020 Apr 8;27(4):556–570.e6. doi: 10.1016/j.chom.2020.02.004
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease. J Clin Invest. 2019 May;130(5):2620–2629. doi: 10.1172/JCI137244
   Web of Science ®Google Scholar
• Wu C, Lu W, Zhang Y, et al. Inflammasome activation triggers blood clotting and host death through pyroptosis. Immunity. 2019 Jun;50(6):1401–1411.e4. doi: 10.1016/j.immuni.2019.04.003
   PubMed Web of Science ®Google Scholar
• Rao AK, Vaidyula VR, Bagga S, et al. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease. Thromb Haemost. 2006 Dec;96(6):738–743.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Z, Liu S, et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B. 2020 Apr. doi: 10.1016/j.apsb.2020.04.008
   Web of Science ®Google Scholar
• Balakumar P, Nyo YH, Renushia R, et al. Classical and pleiotropic actions of dipyridamole: not enough light to illuminate the dark tunnel? Pharmacol Res. 2014 Sep;87:144–150. doi: 10.1016/j.phrs.2014.05.008
   PubMed Web of Science ®Google Scholar
• Kuijpers MJ, Nieuwenhuys CM, Feijge MA, et al. Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood. Thromb Haemost. 2005 Jan;93(1):97–105. doi: 10.1160/TH04-02-0091
   PubMed Web of Science ®Google Scholar
• Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020 Apr; pii:blood.2020006000. doi: 10.1182/blood.2020006000
   Web of Science ®Google Scholar
• Connolly SJ, Eikelboom JW, Bosch J, et al. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 2018 Jan;391(10117):205–218. doi: 10.1016/S0140-6736(17)32458-3
   PubMed Web of Science ®Google Scholar